Tumor angiogenesis in predicting the survival of patients with stage I lung cancer

被引:15
|
作者
Medetoglu, Baris [1 ]
Gunluoglu, Mehmet Zeki [1 ]
Demir, Adalet [1 ]
Melek, Huseyin [1 ]
Buyukpinarbasili, Nur [2 ]
Fener, Neslihan [2 ]
Dincer, Seyyit Ibrahim [1 ]
机构
[1] Yedikule Teaching Hosp Chest Dis & Thorac Surg, Dept Thorac Surg, Istanbul, Turkey
[2] Yedikule Teaching Hosp Chest Dis & Thorac Surg, Dept Pathol, Istanbul, Turkey
来源
关键词
ENDOTHELIAL GROWTH-FACTOR; PROGNOSTIC IMPACT; CD105; EXPRESSION; CARCINOMA; VEGF; METASTASIS; DENSITY; CD31;
D O I
10.1016/j.jtcvs.2010.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The effects of angiogenesis on survival were assessed by measuring the tumor microvessel density and vascular endothelial growth factor expression in patients with resected stage I non-small cell lung carcinoma. Methods: The study population included 141 patients who underwent complete resection for stage pT1 and T2 N0 M0 tumors between 1999 and 2007. Lobectomy and pneumonectomy were performed in 131 and 10 patients, respectively. Tumor specimens were analyzed immunohistochemically for staining with anti-CD105 antibody to determine tumor microvessel density and anti-vascular endothelial growth factor antibody to determine the vascular endothelial growth factor expression level. Univariate and multivariate analyses were performed for factors influencing patients' survival. Results: The overall 5-year survival was calculated as 68%, with rates of 76.9% for patients with T1 disease and 66.2% for patients with T2 disease (P = .4). The vascular endothelial growth factor expression rate was 94.3% for patients with stage I non-small cell lung carcinoma. Vascular endothelial growth factor expression did not influence survival (P = .9). The median microvessel density of the tumors measured based on the level of CD105 expression was 19.8. The effect of microvessel density on survival was significant (P = .02). The 5-year survivals of patients with tumors with 20 or more microvessels and less than 20 microvessels were 76.8% and 56.1%, respectively; this difference was highly significant (P = .004). The microvessel density was determined as an independent factor influencing survival on multivariate analysis (P = .03). Conclusions: The level of vascular endothelial growth factor expression in tumors was not a successful predictor of survival in patients with resected stage I non-small cell lung carcinoma. A high microvessel density based on CD105 is a strong predictor of prognosis in these patients. (J Thorac Cardiovasc Surg 2010;140:996-1000)
引用
收藏
页码:996 / 1000
页数:5
相关论文
共 50 条
  • [21] Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survival
    Obermair, A
    Wanner, C
    Bilgi, S
    Speiser, P
    Kaider, A
    Reinthaller, A
    Leodolter, S
    Gitsch, G
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (02) : 314 - 319
  • [22] Predicting Survival in Potentially Curable Lung Cancer Patients
    Thida Win
    Linda Sharples
    Ashley M. Groves
    Andrew J. Ritchie
    Francis C. Wells
    Clare M. Laroche
    Lung, 2008, 186 : 97 - 102
  • [23] Predicting survival in potentially curable lung cancer patients
    Win, Thida
    Sharples, Linda
    Groves, Ashley M.
    Ritchie, Andrew J.
    Wells, Francis C.
    Laroche, Clare M.
    LUNG, 2008, 186 (02) : 97 - 102
  • [24] Management of Patients With Stage I Lung Cancer
    Bogart, Jeffrey A.
    Wallen, Jason
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (02) : 69 - +
  • [25] MODEL PREDICTING SURVIVAL IN STAGE-I MELANOMA BASED ON TUMOR PROGRESSION
    CLARK, WH
    ELDER, DE
    GUERRY, D
    BRAITMAN, LE
    TROCK, BJ
    SCHULTZ, D
    SYNNESTVEDT, M
    HALPERN, AC
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24): : 1893 - 1904
  • [26] Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer - Discussion
    Holmes, EC
    Rahman, AN
    Ferguson, MK
    Duarte
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (03): : 658 - 659
  • [27] SURVIVAL IMPROVES IN STAGE IV LUNG CANCER PATIENTS
    Matata, B.
    Shaw, M.
    Maguire, J.
    Ledson, M.
    THORAX, 2017, 72 : A224 - A225
  • [28] The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I–III colorectal cancer
    Hailun Xie
    Lishuang Wei
    Mingxiang Liu
    Yanren Liang
    Qiwen Wang
    Shuangyi Tang
    Jialiang Gan
    Scientific Reports, 13
  • [29] Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma
    Shibusa, T
    Shijubo, N
    Abe, S
    CLINICAL CANCER RESEARCH, 1998, 4 (06) : 1483 - 1487
  • [30] Predicting recurrence following curative surgery in stage I non-small cell lung cancer patients using an angiogenesis-associated factor
    Ohta, Y.
    Tanaka, Y.
    Watanabe, G.
    Minato, H.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2007, 26 (03) : 301 - 305